New genetic links in eosinophilic esophagitis

Genome Medicine

Volumn 2, Issue 9, 2010, Pages

  Spergel, Jonathan M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EOTAXIN 3; INTERLEUKIN 13; INTERLEUKIN 5; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL PH MONITORING; ESOPHAGUS BIOPSY; GASTROESOPHAGEAL REFLUX; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETICS; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL;

EID: 78751684368     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm181     Document Type: Note

References (18)

1. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133:1342-1363. 10.1053/j.gastro.2007.08.017, 17919504.
2. Spergel JM, Book W, Mays E, Song L, Shah S, Talley N, Bonis P. Variation in prevalence and practice styles for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr
3. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, Liacouras CA. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009, 48:30-36. 10.1097/MPG.0b013e3181788282, 19172120.
4. Jyonouchi S, Brown-Whitehorn TA, Spergel JM. Association of eosinophilic gastrointestinal disorders with other atopic disorders. Immunol Allergy Clin North Am 2009, 29:85-97. 10.1016/j.iac.2008.09.008, 19141344.
5. Blanchard C, Rothenberg ME. Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008, 18:133-143. x, 10.1016/j.giec.2007.09.016, 2194642, 18061107.
6. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006, 116:536-547. 10.1172/JCI26679, 1359059, 16453027.
7. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, Collins MH, Putnam PE, Wells SI, Rothenberg ME. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007, 120:1292-1300. 10.1016/j.jaci.2007.10.024, 18073124.
8. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007, 119:206-212. 10.1016/j.jaci.2006.10.016, 17208603.
9. Malerba G, Lauciello MC, Scherpbier T, Trabetti E, Galavotti R, Cusin V, Pescollderungg L, Zanoni G, Martinati LC, Boner AL, Levitt RC, Pignatti PF. Linkage analysis of chromosome 12 markers in Italian families with atopic asthmatic children. Am J Respir Crit Care Med 2000, 162:1587-1590.
10. Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010, 65:109-116. 10.1111/j.1398-9995.2009.02142.x, 19796194.
11. Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, Gober L, Kim C, Glessner J, Frackelton E, Thomas K, Blanchard C, Liacouras C, Verma R, Aceves S, Collins MH, Brown-Whitehorn T, Putnam PE, Franciosi JP, Chiavacci RM, Grant SF, Abonia JP, Sleiman PM, Hakonarson H. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010, 42:289-291. 10.1038/ng.547, 20208534.
12. Liu YJ. TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol 2009, 101:1-25. full_text, 19231591.
13. Sherrill JD, Gao P, Stucke EM, Blanchard C, Collins MH, Putman PE, Franciosi JP, Kushner JP, Abonia JP, Assa'ad AH, Kovacic MB, Biagini JM, Bochner BS, He H, Hershey GK, Martin LJ, Rothenberg ME. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010, 126:160-165. 10.1016/j.jaci.2010.04.037, 20620568.
14. Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DY, Barnes KC. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 2010, 125:1403-1407. e4, 10.1016/j.jaci.2010.03.016, 20466416.
15. He JQ, Hallstrand TS, Knight D, Chan-Yeung M, Sandford A, Tripp B, Zamar D, Bosse Y, Kozyrskyj AL, James A, Laprise C, Daley D. A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness. J Allergy Clin Immunol 2009, 124:222-229. 10.1016/j.jaci.2009.04.018, 19539984.
16. NCT01056783: Proof of Concept Study of OC000459 in Eosinophilic Esophagitis. , http://clinicaltrials.gov/ct2/show/NCT01056783
17. NCT00638456: Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis. , http://clinicaltrials.gov/ct2/show/NCT00638456?term=NCT00638456
18. NCT00538434: Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years. , http://clinicaltrials.gov/ct2/show/NCT00538434?term=NCT00538434